首页> 美国卫生研究院文献>Korean Journal of Ophthalmology : KJO >The Development of Recurrent Choroidal Neovascularization in a Patient with Choroidal Coloboma
【2h】

The Development of Recurrent Choroidal Neovascularization in a Patient with Choroidal Coloboma

机译:脉络膜大肠癌患者复发性脉络膜新血管形成的发展

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We report a case of recurrent choroidal neovascularization (CNV) in an eye with chorioretinal coloboma. A 36-year-old woman presented complaining of decreased visual acuity (VA) in her left eye. Best corrected visual acuity (BCVA) was 20/200 and iris coloboma was observed. Funduscopy and fluorescein angiography (FA) showed CNV in the superior extrafoveal region with chorioretinal coloboma reaching just inferior to the optic disc. No other cause for CNV was observed except for the chorioretinal coloboma. BCVA improved to 20/30 after laser photocoagulation. She revisited our clinic for deteriorating VA (20/400) in the same eye 3 years after treatment. Funduscopy and FA demonstrated recurrent CNV with subfoveal hemorrhage. Photodynamic therapy (PDT) was followed by three consecutive intravitreal bevacizumab injections (IVB) for the subfoveally-located CNV. However, the CNV persisted with the appearance of a fresh subretinal hemorrhage. Additional PDT was combined with IVB on the same day 6 months after the initial PDT. The CNV regressed 3 months after treatment and has not recurred as of 8 months after the last treatment. The patient's BCVA improved to 20/60. This case suggests that PDT combined with IVB can be an alternative treatment for the management of recurrent CNV after laser photocoagulation in eyes with chorioretinal coloboma.
机译:我们报告了一例脉络膜视网膜结肠炎的复发性脉络膜新生血管(CNV)。一名36岁的妇女抱怨左眼视力(VA)下降。最佳矫正视力(BCVA)为20/200,并且观察到虹膜虹膜瘤。眼底镜检查和荧光素血管造影(FA)显示中央凹上方上区域的CNV,脉络膜视网膜前淋巴瘤仅次于视盘。除了脉络膜视网膜结肠炎以外,未观察到其他引起CNV的原因。激光光凝后,BCVA提高到20/30。她在治疗3年后再次访问我们的诊所,发现同一只眼中的VA(20/400)恶化。眼底镜检查和FA证实了CNV伴小凹下出血的复发。光动力疗法(PDT)之后是连续3次玻璃体内贝伐单抗注射(IVB)用于位于凹下的CNV。但是,CNV持续伴有新鲜的视网膜下出血。初始PDT后6个月的同一天,将其他PDT与IVB合并。 CNV在治疗后3个月消退,而在最后一次治疗后8个月没有复发。患者的BCVA改善至20/60。这种情况表明PDT联合IVB可以替代治疗脉络膜视网膜性大肠癌眼中激光光凝后复发的CNV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号